Stakeholder group | Participants in round 1 (n = 250) | Participants in round 2 (n = 201) |
---|---|---|
Public and patient representatives | 57 | 46 |
Research ethics committee members and other approvals staff | 36 | 33 |
Industry (including medico-legal experts) | 24 | 15 |
Applied researchers, including psychologists and risk communicators | 26 | 18 |
Research nurses, clinical trial managers and trialists | 84 | 74 |
Others (including quality assurance managers, quality assurance auditors, clinical auditors, pharmacists, PhD students, sponsor representatives, research midwives and principal scientists) | 23 | 15 |